Navigation Links
EAU launches new clinical guidelines for 2009 -- kidney cancer
Date:3/17/2009

Arnhem, The Netherlands A number of updated guidelines will be presented at the 24th Annual Congress of the European Association of Urology (EAU) held in Stockholm, from 17 though 21 March. The abridged versions - Pocket Guidelines which are based on the extended text documents will also be available in Stockholm to all EAU members and press.

Production of clinical guidelines is one of the core activities of the organisation. Close to 150 experts split up over 18 different topic-oriented panels, are involved in this ongoing process. Guidelines aim to present the best evidence available on a given pathology and provide a standardized approach to the treatment of urological conditions. Ultimately, healthcare professionals must make their own decisions about care on a case-by-case basis, after consultation with their patients, using their clinical judgment, knowledge and expertise.

Kidney Cancer

Due to the enhanced use of imaging techniques over the past years a stage shift has been seen in the field of renal cell cancer with a volume increase in the incidental detection of smaller cancers (< 4 cm). Thirty percent of these findings are benign. The treatment of metastatic small tumours show a decrease in death rates. A considerable portion of these tumours can be treated with nephron sparing surgery. Additionally, a number of targeted agents have become available with several more expected shortly.

The panel updated these Kidney Cancer guidelines since for several targeted agents more mature data have been published and validated prognostic nomograms predicting treatment outcome accuracy are available for more treatment options.

The panel do not recommend Interferon-alpha (IFN-alpha) in a first-line setting as monotherapy in the treatment of metastatic RCC. Sunitinib and Bevacizumab + IFN-alpha are recommended as first-line therapy in low- and intermediate-risk patients while

Temsirolimus is recommended for high risk patients; Sorafenib and Everolimus can be recommended as second-line therapy after cytokine and tyrosine kinase inhibitor (TKI) failure, respectively.

The expectation is that further targeted agents will be on the market shortly. Also the role of molecular medicine in the treatment of renal cell carcinoma will become more prominent. A subsequent update will take this information in, once sufficiently data is available.

The panel consists of an expert group chaired by B. Ljungberg and includes D.C. Hanbury, M.A. Kuczyk, A.S. Merseburger, P.F.A. Mulders, J-J. Patard and I.C. Sinescu.


'/>"/>

Contact: Lindy Brouwer
l.brouwer@uroweb.org
European Association of Urology
Source:Eurekalert

Related medicine news :

1. MIT scientist launches special nanoscience symposia at ACS National Meeting
2. ESA launches first Earth Explorer mission GOCE
3. HRSA Launches Online Resource to Help Prevent Poisonings
4. HealthyPlace.com, the Largest Consumer Mental Health Site, Launches Mediminder, a Free Medication Reminder Tool for the More Than 30 Million People Who Suffer From Depression, Anxiety, Bipolar Disorder and Other Mental Health Conditions
5. Cardinal Health Launches New Products for the Operating Room
6. GeoFitness Launches Get Moving America Campaign to Improve Youth Health
7. Health Integrated Launches Unique Service for Health Plans Preparing for Federal Mental Health Parity Regulations
8. Confidential Listening Service We Just Listen Launches, Providing Americans a Private Platform to Express Their Thoughts and Feelings
9. eCardio Diagnostics Launches Academic Medicine Initiative
10. MorseLife Launches Learning Institute to Teach Best Practices in Leadership, Healthcare and Kosher Culinary
11. ADA Launches Community Dental Health Coordinator Program to Provide Dental Care in Underserved Areas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Charlottesville, Virginia (PRWEB) , ... January 18, 2017 , ... ... New studies are released almost daily linking gut health to chronic disease, mental health ... the New Year ” as an important resolution to consider. , For one Charlottesville ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... Maryland Fischell Department of Bioengineering are collaborating on a research project focused on ... bioengineering, the project seeks to use nanotechnology to control the disease without compromising ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... industry’s leading journal and most-read publication among specialty pharmacists and pharmacy professionals, ... through its Strategic Alliance Partnership (SAP) program, announced Brian Haug, president of ...
(Date:1/18/2017)... ... 18, 2017 , ... A Palm Beach doctor plans to run the 2017 ... that provides free surgery to poor children suffering from cleft lip and cleft palate. ... run to support the efforts of the American Heart Association and the Leukemia and ...
(Date:1/18/2017)... , ... January 18, 2017 , ... The Portee Insurance ... families and business owners in central Maryland and the DC region, is inaugurating a ... kills 787,000 people nationally every year, making it the #1 killer in America. However, ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... Research and Markets has announced the addition ... report to their offering. ... The global CINV drugs market to grow at ... Global Thoracic Surgery Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
(Date:1/18/2017)... 17, 2017  With an annual growth ranging from 6% to 10%, ... (Jakarta International Expo, March 22-24, 2017) serves the industry by fostering the regional ... SEA 2017? Investment Forum ASEAN -- ... Richer conference content Enhanced business matchmaking program ... ...
(Date:1/18/2017)... 18, 2017   Seno Medical Instruments, Inc. , ... cancer through the development of an opto-acoustic (OA/US) imaging ... as SVP of Engineering. Mr. Miller previously served ... SonoSite, with headquarters in Bothell, Washington ... 30-year career to the development of innovative medical imaging ...
Breaking Medicine Technology: